We recruited a larger sample size (n = 19) for a 25% loss follow-up
Nitric oxide: physiology, pathophysiology, and pharmacology, Pharmacol
doi: 10.1186/s12974-022-02642-4 55 TahaM.Kyluik-PriceD.KumaranD.ScottM
Patients with an unresponsive and very active phase of their disease received a daily dose of LDN in addition to standard treatment
Alahmadi et al., 2024)
dorzolamide, brinzolamide) Local administration of felypressin in dental anaesthesia NOTE The detection in an Athletes Sample at all times or In-Competition , as applicable, of any quantity of the following substances subject to threshold limits: formoterol, salbutamol, cathine, ephedrine, methylephedrine and pseudoephedrine, in conjunction with a diuretic or masking agent (except topical ophthalmic administration of a carbonic anhydrase inhibitor or local administration of felypressin in dental anaesthesia), will be considered as an Adverse Analytical Finding (AAF) unless the Athlete has an approved Therapeutic Use Exemption (TUE) for that substance in addition to the one granted for the diuretic or masking agent